Onco Wiki / Biomarker

TP53 R273H DNA-Kontakt Hotspot

Deterministische Ansicht der Quelle YAML Entität. Klinische Autorität bleibt mit den zitierten Quell-IDs und Rezensenten Sign-off Zustand.

IDBIO-TP53-R273H
ArtBiomarker
Aliase
DNA-KontaktmutantTP53 R273H DNA-Kontakt Hotspot-MutationTP53 R273H — hotspot ДНК-контактуTP53 p.R273Hp53 R273H
Statusreviewed 2026-04-27 | pending_clinical_signoff
ErkrankungenNone declared
QuellenSRC-NCCN-AML-2025 SRC-NCCN-BCELL-2025 SRC-NCCN-MM-2025

Biomarker-Fakten

Biomarker-Typgene_mutation
Angaben zur Mutation{"exon": "8", "functional_impact": "loss_of_function (DNA-contact residue lost) + gain-of-function (chemoresistance, migration, GOF transcriptional rewiring)", "gene": "TP53", "gene_hugo_id": "11998", "hgvs_coding": "c.818G>A", "hgvs_protein": "p.R273H", "variant_type": "missense"}
Messung
VerfahrenTumor-Gewebe NGS-Panel (TP53 Hotspot oder Vollgen); FFPE akzeptabel; ctDNA NGS für flüssige Biopsie
Einheitencategorical (positive | negative); VAF % for clonality assessment
Verwandte BiomarkerBIO-TP53-MUTATION BIO-TP53-R175H BIO-TP53-R248Q BIO-TP53-R282W

Anmerkungen

R273 is among the top three most-mutated TP53 codons (with R175 and R248). DNA-contact class: R273 directly contacts the DNA major groove via its guanidinium side chain. R→H substitution preserves the thermal stability of the protein fold (distinguishing it from structural R175H) but eliminates specific DNA binding. R273H is one of the best-characterized GOF p53 mutants — promotes chemoresistance via NF-κB activation, drives invasion/metastasis through CXCR4 and RhoA pathways, reprograms metabolism (mevalonate pathway upregulation). Clinical implications mirror the TP53-mutant class: AML/MDS — venetoclax-azacitidine + alloSCT consideration; CLL/MCL — contraindicates chemoimmuno; MM — high-risk cytogenetics composite routes to quadruplet. Notably, R273H tumors are particularly resistant to platinum chemotherapy across solid-tumor types per multiple correlative analyses — relevant for ovarian, lung, esophageal cancer treatment selection.

Verwendet von

Biomarker